Publication | Open Access

Tumour mutational burden as a biomarker in patients with mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer treated with immune checkpoint inhibitors

MedicineImmune Checkpoint InhibitorsImmunologyColorectal CancerPathologyCancer GenomicsImmune Checkpoint InhibitorTumour Mutational BurdenCancer GeneticsMolecular DiagnosticsOncology